Global Cord Blood Corporation (CO)
KYG393421030 - Common Stock
| 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | 2018 (2018-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.66B | 6.08B | 5.47B | 5.00B | 4.25B | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 216.20M | 135.07M | 110.30M | 107.70M | 117.00M | |||
| Inventories | 45.88M | 44.26M | 43.80M | 27.60M | 27.70M | |||
| Other Current Assets | 11.94M | 43.01M | 38.80M | 14.70M | 13.10M | |||
| Total Current Assets | 6.94B | 6.30B | 5.67B | 5.15B | 4.41B | |||
| Non-Current Assets | ||||||||
| PPE Net | 476.69M | 503.69M | 527.20M | 545.30M | 553.00M | |||
| Investments And Advances | 282.30M | 307.04M | 290.40M | 296.50M | 343.00M | |||
| Intangibles | 83.58M | 88.20M | 92.80M | 97.40M | 102.10M | |||
| Other Non-Current Assets | 502.15M | 492.04M | 483.20M | 358.90M | 336.20M | |||
| Total Non-Current Assets | 1.60B | 1.61B | 1.55B | 1.40B | 1.44B | |||
| TOTAL ASSETS | 8.53B | 7.91B | 7.22B | 6.55B | 5.84B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 124.42M | 114.04M | 93.80M | 58.90M | 55.50M | |||
| Accounts Payable | 8.33M | 9.48M | 20.00M | 33.60M | 11.40M | |||
| Other Current Liabilities | 513.81M | 502.95M | 457.00M | 503.20M | 401.30M | |||
| Total Current Liabilities | 646.56M | 626.47M | 570.80M | 595.60M | 468.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 24.28M | 16.13M | 18.10M | 19.60M | 20.60M | |||
| Other Non-Current Liabilities | 2.98B | 2.88B | 2.74B | 2.51B | 2.24B | |||
| Total Non-Current Liabilities | 3.01B | 2.90B | 2.77B | 2.54B | 2.26B | |||
| TOTAL LIABILITIES | 3.66B | 3.52B | 3.34B | 3.13B | 2.73B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 2.89B | 2.39B | 1.88B | 1.41B | 1.12B | |||
| Additional Paid In Capital | 2.10B | 2.10B | 2.10B | 2.10B | 2.05B | |||
| Minority Interest | -2.76M | -1.36M | -600.00K | 1.30M | 1.60M | |||
| Common Shares | 83.00K | 83.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -2.81M | -2.81M | -2.80M | -2.80M | -2.80M | |||
| Other Shareholders' Equity | -106.79M | -103.18M | -94.70M | -88.70M | -54.70M | |||
| Shares Outstanding | 121.55M | 121.55M | 121.60M | 121.60M | 120.80M | |||
| Tangible Book Value per Share | 39.45 | 35.32 | 31.16 | 27.30 | 24.93 | |||
| Total Shareholders' Equity | 4.88B | 4.38B | 3.88B | 3.42B | 3.11B | |||
| TOTAL LIABILITIES AND EQUITY | 8.53B | 7.91B | 7.22B | 6.55B | 5.84B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.73 | 10.05 | 9.93 | 8.64 | 9.42 | |||
| Return On Assets (ROA) | 5.87% | 6.43% | 6.52% | 4.44% | 4.06% | |||
| Return On Equity (ROE) | 10.27% | 11.60% | 12.12% | 8.52% | 7.62% | |||
| Return On Invested Capital (ROIC) | 6.10% | 5.91% | 6.64% | 5.06% | 4.11% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 39.20% | 35.75% | 37.56% | 31.49% | 19.64% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 42.07% | 38.58% | 40.78% | 35.06% | 21.60% | |||
All data in CNY